These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32174326)

  • 1. Cheminformatic modelling of β-amyloid aggregation inhibitory activity against Alzheimer's disease.
    Kumar V; Ojha PK; Saha A; Roy K
    Comput Biol Med; 2020 Mar; 118():103658. PubMed ID: 32174326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer's disease.
    Kumar V; Ojha PK; Saha A; Roy K
    SAR QSAR Environ Res; 2020 Feb; 31(2):87-133. PubMed ID: 31865778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer's Disease.
    Purgatorio R; Gambacorta N; Catto M; de Candia M; Pisani L; Espargaró A; Sabaté R; Cellamare S; Nicolotti O; Altomare CD
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.
    Aswathy L; Jisha RS; Masand VH; Gajbhiye JM; Shibi IG
    In Silico Pharmacol; 2018; 6(1):12. PubMed ID: 30607325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemometric design to explore pharmacophore features of BACE inhibitors for controlling Alzheimer's disease.
    Hossain T; Mukherjee A; Saha A
    Mol Biosyst; 2015 Feb; 11(2):549-57. PubMed ID: 25435329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V; Saha A; Roy K
    Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.
    Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y
    J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
    Palakurti R; Vadrevu R
    Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
    Mitra I; Saha A; Roy K
    J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quick and efficient quantitative predictions of androgen receptor binding affinity for screening Endocrine Disruptor Chemicals using 2D-QSAR and Chemical Read-Across.
    Banerjee A; De P; Kumar V; Kar S; Roy K
    Chemosphere; 2022 Dec; 309(Pt 1):136579. PubMed ID: 36174732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.